RFK Jr. & claimed regenerative peptides like BPC 157 The Niche BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy FDA considers adding a dozen peptides to its bulk drug compounding list RAPS